TransCorp Spine Receives FDA 510(k) Clearance for the SpinePortTM Spinal Access System for Minimally-Invasive Access and Visualization of the Cervical Spine
TransCorp Spine announced today that it recevied FDA 510(k) clearance for its SpinePort Spinal Access System. The SpinePort System provides direct access and visualization to aide surgeons in treating cervical spine pathologies through a transcorporeal microdecompression procedure. The SpinePort System can also be used to harvest local autograft bone eliminating the need for a second inicision during cervical fusion procedures. - June 14, 2012
TransCorp Spine Names Christopher Welch President and Chief Executive Officer
TransCorp Spine, Inc., a privately-held medical device company focused on developing minimally-invasive, tissue-saving products and procedures, today named Christopher Welch President and Chief Executive Officer. Mr. Welch brings a wealth of executive and industry experience to TransCorp Spine... - May 29, 2012